High-dose erythropoietin and hypothermia for hypoxic-Ischemic encephalopathy: A phase II trial

Pediatrics

Volumn 137, Issue 6, 2016, Pages

  Wu, Yvonne W ^a   Mathur, Amit M ^b   Chang, Taeun ^b,c   McKinstry, Robert C ^c   Mulkey, Sarah B ^d   Mayock, Dennis E ^e   Van Meurs, Krisa P ^e   Rogers, Elizabeth E ^a   Gonzalez, Fernando F ^a   Comstock, Bryan A ^f   Juul, Sandra E ^g   Msall, Michael E ^e   Bonifacio, Sonia L ^e   Glass, Hannah C ^a,g   Massaro, An N ^c   Dong, Lawrence ^a   Tan, Katherine W ^f   Heagerty, Patrick J ^h   Ballard, Roberta A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; PLACEBO; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN;

ALBERTA INFANT MOTOR SCALE; APGAR SCORE; ARTICLE; BRAIN INJURY; CEREBELLUM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INJURY SEVERITY; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MALE; MENTAL DEVELOPMENT ASSESSMENT; MOTOR PERFORMANCE; MULTICENTER STUDY; MULTIPLE DRUG DOSE; NERVOUS SYSTEM DEVELOPMENT; NEURORADIOLOGY; NEWBORN; NEWBORN DEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERINATAL DEPRESSION; PERSISTENT PULMONARY HYPERTENSION; PHASE 2 CLINICAL TRIAL; POLYCYTHEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SCORING SYSTEM; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT RESPONSE; WARNER INITIAL DEVELOPMENTAL EVALUATION; BRAIN; BRAIN INJURIES; CLASSIFICATION; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION; HYPOTHERMIA; HYPOXIA-ISCHEMIA, BRAIN; INTRAVENOUS DRUG ADMINISTRATION; MOTOR SKILLS DISORDERS; NEURODEVELOPMENTAL DISORDERS; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

BRAIN; BRAIN INJURIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FEMALE; HUMANS; HYPOTHERMIA; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MOTOR SKILLS DISORDERS; NEURODEVELOPMENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84971524629     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-0191     Document Type: Article

References (69)

1. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86(6):329-338.
2. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol. 2008;199(6):587-595.
3. Black RE, Cousens S, Johnson HL, et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: A systematic analysis. Lancet. 2010;375(9730):1969-1987.
4. Shankaran S, Laptook AR, Ehrenkranz RA, et al; National Institute of Child Health and Human Development Neonatal Research Network. Wholebody hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353(15):1574-1584.
5. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet. 2005;365(9460):663-670.
6. Jacobs SE, Morley CJ, Inder TE, et al; Infant Cooling Evaluation Collaboration. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165(8):692-700.
7. Simbruner G, Mittal RA, Rohlmann F, Muche R; neo.nEURO.network Trial Participants. Systemic hypothermia after neonatal encephalopathy: Outcomes of neo.nEURO.network RCT. Pediatrics. 2010;126(4). Available at: www.pediatrics.org/cgi/content/full/126/4/e771.
8. Azzopardi DV, Strohm B, Edwards AD, et al; TOBY Study Group. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361(14):1349-1358.
9. Shankaran S, Pappas A, McDonald SA, et al; Eunice Kennedy Shriver NICHD Neonatal Research Network. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366(22):2085-2092.
10. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr Suppl. 2002;91(438):36-42.
11. Juul SE, McPherson RJ, Bammler TK, Wilkerson J, Beyer RP, Farin FM. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev Neurosci. 2008;30(4):231-242.
12. Juul S. Recombinant erythropoietin as a neuroprotective treatment: In vitro and in vivo models. Clin Perinatol. 2004;31(1):129-142.
13. Demers EJ, McPherson RJ, Juul SE. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res. 2005;58(2):297-301.
14. Dame C, Juul SE, Christensen RD. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate. 2001;79(3-4):228-235.
15. Reitmeir R, Kilic E, Kilic U, et al. Postacute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity. Brain. 2011;134(pt 1):84-99.
16. Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: Safety and pharmacokinetics. Pediatrics. 2012;130(4):683-691.
17. Rogers EE, Bonifacio SL, Glass HC, et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol. 2014;51(5):657-662.
18. Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxicischemic encephalopathy. Pediatrics. 2009;124(2). Available at: www. pediatrics.org/cgi/content/full/124/2/e218.
19. Elmahdy H, El-Mashad AR, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H. Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics. 2010;125(5). Available at: www.pediatrics.org/cgi/content/full/125/5/e1135.
20. Perlman JM, Wyllie J, Kattwinkel J, et al; Neonatal Resuscitation Chapter Collaborators. Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics. 2010;126(5). Available at: www.pediatrics.org/cgi/content/full/126/5/e1319.
21. Kattwinkel J, Perlman JM, Aziz K, et al. Part 15: Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 suppl 3):S909-S919.
22. Azzopardi D, Strohm B, Linsell L, et al; UK TOBY Cooling Register. Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK- analysis of national data. PLoS One. 2012;7(6):e38504.
23. Davidson JO, Wassink G, van den Heuij LG, Bennet L, Gunn AJ. Therapeutic hypothermia for neonatal hypoxicischemic encephalopathy-Where to from here? Front Neurol. September 2015;6:198.
24. Ohls RK, Christensen RD, Widness JA, Juul SE. Erythropoiesis stimulating agents demonstrate safety and show promise as neuroprotective agents in neonates. J Pediatr. 2015;167(1):10-12.
25. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33(10):696-705.
26. Yildirim ZH, Aydinli N, Ekici B, Tatli B, Caliskan M. Can Alberta Infant Motor Scale and milani comparetti motor development screening test be rapid alternatives to bayley scales of infant development-II at high-risk infants. Ann Indian Acad Neurol. 2012;15(3):196-199.
27. Darrah J, Piper M, Watt MJ. Assessment of gross motor skills of at-risk infants: predictive validity of the Alberta Infant Motor Scale. Dev Med Child Neurol. 1998;40(7):485-491.
28. Piper MC, Pinnell LE, Darrah J, Maguire T, Byrne PJ. Construction and validation of the Alberta Infant Motor Scale (AIMS). Can J Public Health. 1992;83(suppl 2):S46-S50.
29. Darrah J, Redfern L, Maguire TO, Beaulne AP, Watt J. Intra-individual stability of rate of gross motor development in full-term infants. Early Hum Dev. 1998;52(2):169-179.
30. Spittle AJ, Doyle LW, Boyd RN. A systematic review of the clinimetric properties of neuromotor assessments for preterm infants during the first year of life. Dev Med Child Neurol. 2008;50(4):254-266.
31. Msall ME. Measuring functional skills in preschool children at risk for neurodevelopmental disabilities. Ment Retard Dev Disabil Res Rev. 2005;11(3):263-273.
32. Msall M, Tremont MR, Ottenbacher KJ. Functional assessment of preschool children: Optimizing developmental and family supports in early intervention. Infants Young Child. 2001;14(1):46-66.
33. Park JJ. Development of a Functional Assessment Tool in Children Birth to 36 Months: Validation Study of the Warner Initial Developmental Evaluation of Adaptive and Functional Skills (Warner IDEA-FS) in Typical and Atypical Children. Chicago, IL: Liberal Arts Program, Graham School of Continuing Liberal and Professional Studies, University of Chicago; 2010.
34. Bednarek N, Mathur A, Inder T, Wilkinson J, Neil J, Shimony J. Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy. Neurology. 2012;78(18):1420-1427.
35. Barkovich AJ, Miller SP, Bartha A, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006;27(3):533-547.
36. Ment LR, Bada HS, Barnes P, et al. Practice parameter: Neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;58(12):1726-1738.
37. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
38. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke. 2004;35(7):1732-1737.
39. Wallach I, Zhang J, Hartmann A, et al. Erythropoietin-receptor gene regulation in neuronal cells. Pediatr Res. 2009;65(6):619-624.
40. Sugawa M, Sakurai Y, Ishikawa- Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44(4):391-403.
41. Chong ZZ, Kang JQ, Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol. 2003;138(6):1107-1118.
42. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves crosstalk between Jak2 and NF-kappaB signalling cascades. Nature. 2001;412(6847):641-647.
43. Xiong T, Qu Y, Mu D, Ferriero D. Erythropoietin for neonatal brain injury: Opportunity and challenge. Int J Dev Neurosci. 2011;29(6):583-591.
44. Kellert BA, McPherson RJ, Juul SE. A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res. 2007;61(4):451-455.
45. Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke. 2005;36(8):1672-1678.
46. Juul SE, Beyer RP, Bammler TK, McPherson RJ, Wilkerson J, Farin FM. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr Res. 2009;65(5):485-492.
47. Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38(10):2795-2803.
48. Ransome MI, Turnley AM. Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis. J Neurochem. 2007;102(6):1953-1965.
49. Wang L, Chopp M, Gregg SR, et al. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab. 2008;28(7):1361-1368.
50. Yang Z, Covey MV, Bitel CL, Ni L, Jonakait GM, Levison SW. Sustained neocortical neurogenesis after neonatal hypoxic/ischemic injury. Ann Neurol. 2007;61(3):199-208.
51. Gonzalez FF, Larpthaveesarp A, McQuillen P, et al. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke. 2013;44(3):753-758.
52. Gonzalez FF, McQuillen P, Mu D, et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci. 2007;29(4-5):321-330.
53. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: An updated systematic review and metaanalysis. Arch Pediatr Adolesc Med. 2012;166(6):558-566.
54. Shah PS. Hypothermia: A systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med. 2010;15(5):238-246.
55. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med. 2010;15(5):293-298.
56. Salmeen KE, Jelin AC, Thiet MP. Perinatal neuroprotection. F1000Prime Rep. January 2014;6:6.
57. Azzopardi D, Robertson NJ, Bainbridge A, et al. Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): A proofof- concept, open-label, randomised controlled trial. Lancet Neurol. 2015;15(2):145-153.
58. Baserga MC, Beachy JC, Roberts JK, et al. Darbepoetin administration to neonates undergoing cooling for encephalopathy: A safety and pharmacokinetic trial. Pediatr Res. 2015;78(3):315-322.
59. Benders MJ, van der Aa NE, Roks M, et al Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke. J Pediatr. 2014;164(3):481-486.
60. Andropoulos DB, Brady K, Easley RB, et al. Erythropoietin neuroprotection in neonatal cardiac surgery: A phase I/II safety and efficacy trial. J Thorac Cardiovasc Surg. 2013;146(1):124-131.
61. Leuchter RH, Gui L, Poncet A, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA. 2014;312(8):817-824.
62. Ohls RK, Kamath-Rayne BD, Christensen RD, et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics. 2014;133(6):1023-1030.
63. McAdams RM, McPherson RJ, Mayock DE, Juul SE. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol. 2013;33(3):226-230.
64. Ohls RK, Cannon DC, Phillips J, et al. Preschool assessment of preterm infants treated with darbepoetin and erythropoietin. Pediatrics. 2016;137(3):e20153859.
65. Ferriero DM, Miller SP. Imaging selective vulnerability in the developing nervous system. J Anat. 2010;217(4):429-435.
66. Rutherford M, Ramenghi LA, Edwards AD, et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: A nested substudy of a randomised controlled trial. Lancet Neurol. 2010;9(1):39-45.
67. Cheong JL, Coleman L, Hunt RW, et al; Infant Cooling Evaluation Collaboration. Prognostic utility of magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy: Substudy of a randomized trial. Arch Pediatr Adolesc Med. 2012;166(7):634-640.
68. Wu YW, Gonzalez FF. Erythropoietin: A novel therapy for hypoxic-ischaemic encephalopathy? Dev Med Child Neurol. 2015;57(suppl 3):34-39.
69. Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41(5):1032-1037.